Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron dosing in obese breast surgery
NCT02941913Phase 4Completed
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Started Oct 2016; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02941913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941913.